Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
127.50    5.25 (4.29%)
Bid:
128.50
Ask:
129.50
Spread: 1.00 (0.778%)
Market Cap: £203.13m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Pre-close Trading Update

31 Mar 2016 07:00

RNS Number : 6047T
Redcentric PLC
31 March 2016
 

31 March 2016

Redcentric plc

("Redcentric" or the "Company")

 

Pre-close Trading Update

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, is today issuing a pre-close trading update for the second half of the financial year to 31 March 2016.

 

The positive momentum reported at the interim results has continued through the second half of the year. Contracted revenues continue to grow, driven both through new client wins and with existing clients taking more services and products.

 

EBITDA margins have improved as we continue to improve the revenue mix to higher margin services. Overall, revenue and EBITDA are both expected to be in line with expectations.

 

City Lifeline Ltd, which was acquired for £4.8m on 29 January 2016, is performing in line with plan, and its integration into the wider Redcentric business is progressing well.

 

During the second half, the business has increased its success-based capital expenditure given the high levels of new customer activity. Following this expenditure and an increase in year-end debtors, principally reflecting the timing of some collections, the Company's balance sheet remains strong, with a net debt to adjusted EBITDA ratio of below 1.0x.

 

There is good sales momentum, with a strong pipeline of future opportunities. Overall, the Board are confident in the outlook of the business.

 

Redcentric is expecting to report results for the year to 31 March 2016 on 16 June 2016.

 

Fraser Fisher, Chief Executive Officer of Redcentric, commented;

"We're pleased with our performance in the second half of the year. The strength of our business model, with its high proportion of recurring revenue, provides stability from which we can plan our growth. We remain confident in the strength of the business to continue to successfully execute its growth strategy".

 

 

Enquiries:

 

Redcentric plc

+44 (0)845 034 111

Fraser Fisher, Chief Executive Officer

Tim Coleman, Chief Financial Officer

Numis Securities Limited - Nomad & Joint Broker

+44 (0)20 7260 1000

Simon Willis / Oliver Hardy / Ben Stoop

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

MXC Capital Markets LLP - Financial Adviser

+44 (0)20 7965 8149

Marc Young / Charlotte Stranner

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTWGUAAWUPQGAU
Date   Source Headline
8th Jul 20217:00 amRNSBoard Change
7th Jul 20217:00 amRNSHolding(s) in Company
15th Jun 20217:00 amRNSDelay of Full Year Results
28th May 20217:00 amRNSExercise of options
28th Apr 20217:00 amRNSDirectorate Change
13th Apr 20215:27 pmRNSHolding(s) in Company
12th Apr 20212:47 pmRNSHolding(s) in Company
6th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSExercise of Options
9th Mar 20215:00 pmRNSDirector/PDMR Shareholding
8th Mar 202112:52 pmRNSHolding(s) in Company
22nd Feb 20213:15 pmRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
19th Feb 202112:43 pmRNSHolding(s) in Company
8th Jan 20217:00 amRNSExercise of Options
6th Jan 20214:52 pmRNSHolding(s) in Company
6th Jan 20214:52 pmRNSHolding(s) in Company
6th Jan 20214:38 pmRNSHolding(s) in Company
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
22nd Dec 20205:13 pmRNSHolding(s) in Company
22nd Dec 20203:28 pmRNSHolding(s) in Company
21st Dec 20205:18 pmRNSHolding(s) in Company
9th Dec 20207:01 amRNSIssue of Options
9th Dec 20207:00 amRNSExercise of Options
8th Dec 20207:00 amRNSCompletion of Restitution Scheme
30th Nov 20207:00 amRNSRestitution Scheme Update
24th Nov 20207:00 amRNSRestitution Scheme Update
23rd Nov 20207:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
12th Nov 20207:01 amRNSHalf Year Results
12th Nov 20207:00 amRNSEnd of formal sale process
11th Nov 20205:48 pmRNSStatement regarding Redcentric plc
9th Nov 20205:32 pmRNSForm 8.3 - Redcentric Plc
2nd Nov 20204:00 pmRNSRule 2.9 Announcement
2nd Nov 20204:00 pmRNSRestitution Scheme Update
30th Oct 20202:45 pmRNSForm 8.3 - Redcentric PLC
27th Oct 20202:11 pmRNSForm 8.3 - Redcentric PLC
20th Oct 202012:09 pmRNSForm 8.3 - Redcentric Plc
19th Oct 20207:02 amRNSRule 2.9 Announcement
19th Oct 20207:01 amRNSRestitution Scheme Update
19th Oct 20207:00 amRNSExercise of Options
15th Oct 20207:00 amRNSTrading Update
13th Oct 202012:28 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
13th Oct 202010:31 amRNSForm 8.3 - Redcentric PLC
12th Oct 20203:00 pmRNSForm 8.3 - Redcentric PLC
12th Oct 20207:00 amRNSRule 2.9 Announcement
12th Oct 20207:00 amRNSRestitution Scheme Update
9th Oct 20203:15 pmRNSForm 8.3 - Redcentric PLC
9th Oct 20207:00 amRNSRule 2.9 Announcement
9th Oct 20207:00 amRNSExercise of Options
5th Oct 20207:00 amRNSRule 2.9 Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.